The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent insulin secretion, suppressed glucagon secretion, and reduced appetite
[20] Buse JB, Nauck M, Forst T, et al
One such option is semaglutide, an FDA-approved medication that has shown significant promise in helping adults achieve and maintain a healthy weight
No effects on blood pressure, body weight, BMI, lean mass, fat mass and ratio hip/waist were observed
Over-prescribing or failing to provide appropriate oversight and management of a patients condition could fall below this standard and may result in regulatory or professional consequences
When the study group was stratified by BMI, adults without obesity, those with class I obesity (BMI: 30-34.99 kg/m2) and those with class II obesity (BMI: 35-39.99 kg/m2) were less likely to have all-cause hospital admissions, ED visits, undergo an endoscopic procedure, receive a prescription for a prokinetic, and receive a laxative prescription if they used an incretin-based drug compared with nonusers
